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Table 2
Antibotic susceptibility (according to CLSI guidelines)
S. aureus
(%
sensitive)
#Samples E. coli (%
sensitive)
#Samples K. pneu-
moniae(%
sensitive)
#Samples
Ampicillin 10% 19 0% 8
Augmentin 56% 9 71% 7
Ceftriaxone- 90% I0 57% 7
Chloramphenicol 72% 39 75 8 38% 8
Erythromycin 59% 39
Gentamicin 100% 37 70% 10 75% 8
Oﬂoxacin 100% 9 100% 5
Oﬂoxacin or methicillin 100% 25
Penicillin 6% 36
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Conclusion: A strong correlation existed between emm-
sequence type and bacteriophage-associated super-antigen genesCo-trimaoxazole 97% 31 10% 10 50% 8
Vancomycin 10% 19
ountries. Empiric treatment of neonatal sepsis should include an
gent active against S. aureus, such as cloxacillin with gentamicin
MRSA was not detected).
Alarmingly, we found a high frequency of E. coli resistant to
mpicillin. Antibiotic stewardship and hospital hygiene need to be
igh priorities [6].
Our data suggest a possible role for hot beds in neonatal S. aureus
acteremia.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.782
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everity of hospitalised rotavirus gastroenteritis in South Aus-
ralian children prior to and following implementation of an
nfant rotavirus immunisation program
. Marshall 1,∗, M. Clarke2, Y.Y. Liew3, G. Davidson1
Women’s & Children’s Hospital and University of Adelaide, Adelaide,
outh Australia, Australia
Women’s & Children’s Hospital, Adelaide, South Australia, Australia
Women’s and Children’s Hospital, Adelaide, SA, Australia
Background: A dramatic reduction in the number of hospi-
alisations for acute rotavirus gastroenteritis has been observed
n Australian children following introduction of the rotavirus
mmunisation program in July 2007. This study aimed to assess
nd compare severity of hospitalised rotavirus gastroenteritis in
hildren prior to and following introduction of the rotavirus immu-
isation program.
Methods: Rotavirus gastroenteritis hospitalisations of chil-
ren<5 years of age at a tertiary paediatric hospital, during a
wo year period pre and post rotavirus vaccine introduction, were
eviewed and scored for severity using two internationally recog-
ised gastroenteritis severity scoring systems (Clark and Vesikari)
ll cases had laboratory conﬁrmed rotavirus infection. The sample
ize allowed for >90% power to detect a difference in mean severity
core of 1.5 units.
Results: A total of 203 hospitalisations prior to and 45 hospital-
sations post introduction of rotavirus vaccine were reviewed. Age
f children ranged from 10 days - 4 years 11 months. There were
ore males than females in both periods with 56% males overall
p =0.004). The mean age of children hospitalised was signiﬁ-
antly higher following introduction of the immunisation program
20.4 months prior compared to 32.7 months post introduction;
= <0.001). The mean Clark severity score was 10.8 (10.3-11.2)fectious Diseases 16S (2012) e158–e316 e203
prior to vaccine introduction and 10.4 (9.4-11.3) post introduction.
Similarly, the mean Vesikari scores were 13.5 (13.1-13.9) prior to
and 13.4 (12.3-14.4) post introduction of the rotavirus immunisa-
tion program. There was no signiﬁcant difference in proportions
of hospitalised cases scoring moderate-severe, between the pre
and post rotavirus immunisation periods for either severity scale
(Clark: 81% vs 79% and Vesikari: 88% vs 88%). The mean duration
of hospitalisation was 33.2hours (range: 2hours – 10.5 days), with
no signiﬁcant difference in length of stay prior to introduction of
the rotavirus immunisation program (32.3hours, range 5hrs – 10.5
days) compared to post introduction (37.6hrs, range 2hours - 5.6
days; p =0.24).
Conclusion: Rotavirus vaccines have been very successful in
reducing the number of paediatric hospitalisations due to acute
rotavirus gastroenteritis, however our ﬁndings suggest there has
been no impact on the severity of hospitalised cases. An increase
in the mean age at hospitalisation following introduction of the
rotavirus immunisation program was identiﬁed.
http://dx.doi.org/10.1016/j.ijid.2012.05.783
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Prevalence of bacteriophage-associated super-antigen genes in
Streptococcus pyogenes isolated from pediatric patients in Japan
M. Minami ∗, Y. Oshima, M. Kuriyama, T. Hasegawa
Nagoya City University, Nagoya, Japan
Background: Streptococcus pyogenes infection is one of themost
common in pediatric diseases. Lysogenic bacteriophage is included
in the genome of Streptococcus pyogenes. Although prophages com-
prise a small fraction of the Streptococcus pyogenes genome, they
may account for up to 70% of the variation in the gene makeup
of Streptococcus pyogenes. Streptococcal bacteriophage encodes
super- antigen genes that are widely considered to be virulent
factors. In this study, we tried to clarify the recent prevalence of
bacteriophage-associated super antigengenes in Streptococcus pyo-
genes isolated from pediatric patients in Japan.
Methods: We collected 143 clinical Streptococcus pyogenes iso-
lates from children at four medical facilities in Japan from 2009
to 2011. We investigated the presence of 7 known super-antigen
genes carried by prophage; speA, speC, speH, speI, speK, speL,and
speM by PCR methods. The emm types of Streptococcus pyogenes
strains were also determined by the sequencing of the emm gene.
Results: The prevalence of speA, speC, speH, speI, speK, speL and
speM genes were 30.1%, 61.5%, 20.3%, 31.4%, 16.1%, 18.2%, and 7.7%,
respectively. The 19 kinds of emm typeswere observed in 143 clini-
cal isolates. The threemajor emm types of 143 clinical isolateswere
M12, M1, and M89, respectively. The 92% of M1 strains possessed
speA. The 78% of M12 strains, 81% of M89 strains, and 87.5% of M4
strains possessed speC. The 50% of M12 strains possessed speH. The
78% of M12 strains and 75% of M75 strains possessed speI. The 75%
ofM4 strains possessed speK. AllM4 strains possessed speL. AllM75
strains possessed speM.in Streptococcus pyogenes. We suggested that substantial contribu-
e l of Infectious Diseases 16S (2012) e158–e316
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Table 1
Number and percent of infection markers in a sample of pregnant women with high
risk pregnancy
Age group n CMV Rubella Parvovirus HCV HBsAg Syphilis* HIV**
IgM IgM IgM Abs
<21 119 1(0.8) 0 1(0.8) 0 0 0 1(0.8)
21-25 82 1(1.2) 3.7 1(1.2) 0 0 0 2(2.4)
26-30 86 1(1.2) 0 1(1.2) 1(1.2) 0 0 1(1.2)
31-35 85 1(1.2) 1(1.2) 0 0 0 0
>35 105 2(1.9) 1(1.0) 2(1.9) 1(1.0) 0 1(2.5) 3(2.9)
Total 477 6(1.3) 5(1.0) 5(1.0) 2(0.4) 0 1(0.4) 7(1.5)204 15th ICID Abstracts / International Journa
ion to the diversiﬁcation of the Streptococcus pyogenes genome
ttributed to bacteriophage.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.784
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ntegrated management of neonatal and childhood illnesses - A
ost-effective intervention for controlling diarrhoea: Commu-
ity based study conducted in rural India
. Mudey ∗, M. Khapre, G. Mudey, R. Goyal, V. Wagh
Jawaharlal Nehru Medical College, Wardha, Maharashtra, India
Background: One in every four deaths in children below the
ge of 5 years is estimated to be due to diarrhoea. One out of every
en babies born in developing countries fails to reach their ﬁfth
irthday, falling victim to diarrhoeal diseases. Diarrhoea kills more
oung children than AIDS, malaria and measles combined. This
tudy explores the cost-effectiveness of integrating immunization,
eproductive and child health, and behavioural change under one
oof as Integrated Management of Neonatal and childhood illnesses in
ontrolling diarrhoeal diseases.
Methods:Fivehundredand tenchildrenbelowtheageof5years
ere selected by cluster sampling method (30 clusters, 17 chil-
ren in each cluster). Background information was collected from
he mother or caretaker of child using a structured questionnaire.
bservational checklist was used for assessing environmental con-
itions.A childbelowﬁveyearsof agewithacutediarrhoeaeither in
he previous two weeks or at the time of interview was considered
s a case of diarrhoea.
Results: The prevalence of diarrhoea was 20.7%. There was no
tatistically signiﬁcant difference in prevalence of diarrhoea in
ales and females. Among various age groups 7- 12 months had
ighest prevalence of diarrhoea (37.2%) followed by 13-24 months
22.4%). The occurrence of diarrhoea was signiﬁcantly associated
ith poor educational status of mother, low birth weight, history
f measles, not receiving vitamin A prophylaxis in last 6 months,
ot gaining weight adequately, poor breast feeding practices, and
oor hygiene.
Conclusion: One in ﬁve children was affected by diarrhoea.
eaning period was found to be the most crucial time. Low
wareness among illiterate mothers, incomplete immunization,
nder-weight, inappropriate breast feeding practices, poor envi-
onmental conditions increase the susceptibility to diarrhoea. A lot
f necessary information is already available about effective man-
gement of diarrhoea. However, there is lack of critical knowledge
expertise for ensuring accessibility to treatment by those who
eed it the most. If childhood diarrhoea is not addressed urgently,
he countrieswill fail to achieve the fourthMillenniumDevelopment
oal (MDG4) target of reducing child deaths by two-thirds by 2015.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.785*Syphilis frequency was calculated from 223 women, since the laboratory test was
not valid for the rest of the samples; **HIV infection data were gathered from the
questionnaire.
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Frequency of potentially congenital infections in women with
high risk pregnancy in Mexico
S. Murrieta1,∗, A.L. Castan˜eda-Huitrón1, R. Figueroa2, H.
Caballero-Ortega1, D. Correa1
1 Instituto Nacional de Pediatría, México, DF, Mexico
2 Instituto Nacional de Perinatología, México, DF, Mexico
Background: TORCH, HIV and other infections can be vertically
transmitted and provoke abortions or give birth to congenitally
infected newborns, most of who are born subclinical but with high
risk to develop squeals later in life. In Mexico, there are few reports
on the frequency of these infections in pregnant women, and espe-
cially of co-infections.
Methods: Pregnant women attended at the National Institute
of Perinatology are being studied for infection markers of acute or
current infections using commercial ELISAs. The results presented
herein come from the ﬁrst 477 women, who donated serum for
detection of six serologic markers using commercial kits. They also
answered a questionnaire applied to search for clinical related fac-
tors.
Results: The frequency of different infection markers and of co-
infections can be observed in Table 1. The frequency of infections
peaked in the second and last age groups. HIV and CMV were the
commonest infections and no positive case of HBV has been found.
All CMV cases had high IgG avidity, i.e. they were re-infections. A
previously unknown frequency of 1.0% of Parvovirus B19 was also
observed. Syphilis was only detected in a woman from the older
group who also was infected with HIV. Other two co-infections
were observed.
Note: three cases presented co-infections: one HIV+CMV,
another HIV+Syphilis and a third one CMV+Parvovirus B19.
Conclusion: The results seemdifferent to data reported in other
parts of the world, probably due to a) a quite large proportion of
youngwomen; b)markers of acute or current infectionwere looked
for in the cases of CMV, Rubella, Parvovirus andHBV; c) Rubella IgM
is probably reﬂecting response against the vaccine actually being
administered by the Ministry of Health of Mexico, since no case
presented clinical signs of the disease.NOTE: this work was partially ﬁnanced by CONACYT grant No.
69666
http://dx.doi.org/10.1016/j.ijid.2012.05.786
